Firebrick Pharma Ltd (fre) Logo

Firebrick Pharma Ltd (FRE)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

FRE ASX Chart

Snapshot

Firebrick Pharma Limited (FRE) is a pharmaceutical innovator developing and commercialising novel formulations and uses of povidone-iodine (PVP-I). The Company has developed and is now commercialising Nasodine Nasal Spray (0.5% PVP-I) and has several other products in development. It has recently introduced Nasodine in the United States and Singapore.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2025 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +61.17%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,539 of 2,345
Sector Rank 144 of 231

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies NYR / IMC / CCO
EPS -$0.007
DPS $0.00
Book Value Per Share $0.01

Broker Consensus

FRE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Creswick VIC 3363
Website www.firebrickpharma.com
Registry Automic Group
Auditor BDO Audit Pty Ltd
Date Listed 28 Jan 2022

Upcoming Calendar (Forecasted)

Date Event
26/02/2025 Report (Interim)
29/08/2025 Report (Prelim)
29/08/2025 Report (Annual)

Former Company Names

  • Firebrick Pharma Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

FRE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
10/10/24 Stephen Goodall Buy +181,818 $0.055 $10,000 Participation in share purchase plan
10/10/24 Peter Molloy Buy +454,545 $0.055 $25,000 Participation in share purchase plan
27/06/24 Peter Molloy Buy +500,000 $0.057 $28,437 On-market trade
20/06/23 Stephen Goodall Issued 530,000 $0.15 $79,500 Placement
20/06/23 Stephen Goodall Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Stephen Goodall Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Peter Molloy Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Peter Molloy Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Peter Molloy Issued 530,000 $0.15 $79,500 Placement
24/11/22 Phyllis Gardner Issued 100,000 $0.173 $17,325 Director remuneration
24/11/22 Richard Treagus Issued 100,000 $0.173 $17,325 Director remuneration

Director Interests

The current holdings of FRE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Stephen Goodall 10/10/2024 0 31,038,290 N/A N/A
Peter Molloy 10/10/2024 0 31,811,017 N/A N/A
Phyllis Gardner 30/06/2024 600,000 N/A 100,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 11, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Aquarico Pty Ltd <P & C Molloy Family A/C> 30,326,472 15.53%
Biotech Design Pty Ltd 30,326,472 15.53%
GZ Family Holdings Pty Ltd <GZ Family A/C> 23,400,000 11.98%
BNP Paribas Noms Pty Ltd 3,250,017 1.66%
Ms Helen Frances Morgan 2,744,507 1.41%
Mr Ivan Kaufman 2,550,000 1.31%
Dr Jonathan Bryden Dalitz & Mrs Michelle Anne Dalitz <Dalitz Super Fund A/C> 2,500,000 1.28%
Kashflow 18 LLC 2,103,713 1.08%
Zero Nominees Pty Ltd 2,103,691 1.08%
Mr Ian Douglas Robertson 2,074,129 1.06%
The Shed Man Pty Ltd 1,750,000 0.90%
GB & JK Porter Pty Ltd <GB & JK Porter S/F A/C> 1,500,000 0.77%
Bnp Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 1,206,028 0.62%
Greenford Pty Ltd <Kluger Super Fund A/C> 1,200,000 0.61%
GZ Super Investments Pty Ltd <GZ Superannuation Fund A/C> 1,200,000 0.61%
Mrs Jill Robin Margo 1,183,100 0.61%
Mrs Christine Louise Molloy 1,030,000 0.53%
Mr Michael Graeme Duckworth 1,012,358 0.52%
Blake Nominees Pty Ltd <M And T Super Fund A/C> 1,000,000 0.51%
Davivaro Pty Ltd <Rosenfeld Super Fund A/C> 1,000,000 0.51%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 719 1,771 611 852 172 4,125

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Peter Laurence Molloy 11/08/2024 30,856,472 15.80
Stephen Francis Goodall 11/08/2024 30,856,472 15.80
GZ Family Holdings Pty Ltd 11/08/2024 24,600,000 12.60

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
31-05-24 GZ Family Holdings Pty Ltd 15,554,234 5.06 12.60
29-05-24 Peter Laurence Molloy 530,000 17.96 15.80
29-05-24 Stephen Francis Goodall 530,000 17.96 15.80
28-05-24 Peter Laurence Molloy 30,326,472 -- 17.96
28-05-24 Stephen Francis Goodall 30,326,472 -- 17.96
27-03-24 GZ Family Holdings Pty Ltd 9,045,766 -- 5.06

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.056 28 June
2023 $0.155 30 June
2022 $0.265 30 June
FRE Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.